open access

Vol 10, No 1 (2007)
Published online: 2007-02-15
Submitted: 2012-01-23
Get Citation

Labelling of the anti-III-neurotubulin monoclonal antibody by 99mTc and its binding to responsible antigen

Katerina Slapnicková, Petra Kolárová, Klára Kynclová
Nucl. Med. Rev 2007;10(1):1-5.

open access

Vol 10, No 1 (2007)
Published online: 2007-02-15
Submitted: 2012-01-23

Abstract


BACKGROUND: ß-III-neurotubulin is a characteristic degradation protein of cellular cytoskeleton of nervous tissues, which originates with disorders that lead to the loss of peripheral neurons or neurons of the central nervous system. For the diagnostics of neuropathic and neurodegenerative processes, ß-III-neurotubulin is therefore the goal structure, and radioactive labelled antibody TU-20 99mTc could theoretically enable diagnostic application in vivo.
MATERIAL AND METHODS: In our case, were selected three ways of labelling monoclonal antibody IgG1 - TU-20, which shows a high affinity towards ß-III-neurotubulin with 99mTc. The indirect labelling was ensured through the bifunctional chelator HYNIC, the direct labelling by electrolytic means, and the direct labelling of antibody TU-20 reduced by 2-mercaptoethanol. To observe each single feature, the appropriate chemical and biochemical control methods were used. Chemical purity was ensured by gel filtration and, together with chemical stability, it was checked by paper chromatography. To control the biological stability, SDS electrophoresis was used. The immunoreactivity was checked using ELISA-tests.
RESULTS: The results have shown that the optimal method for labelling the antibody TU-20 is indirect labelling through the bifunctional chelator HYNIC, and the least effective method of labelling the antibody TU-20 is reduced by 2-mercaptoethanol.
DISCUSSION: The results of labelling the monoclonal antibody towards antigen TU-20 with 99mTc confirmed that structure of the monoclonal antibody is destroyed by 2-mercaptoethanol, and in the case of electrolytic labelling, there are not enough binding places for radionuclide 99mTc on the monoclonal antibody.

Abstract


BACKGROUND: ß-III-neurotubulin is a characteristic degradation protein of cellular cytoskeleton of nervous tissues, which originates with disorders that lead to the loss of peripheral neurons or neurons of the central nervous system. For the diagnostics of neuropathic and neurodegenerative processes, ß-III-neurotubulin is therefore the goal structure, and radioactive labelled antibody TU-20 99mTc could theoretically enable diagnostic application in vivo.
MATERIAL AND METHODS: In our case, were selected three ways of labelling monoclonal antibody IgG1 - TU-20, which shows a high affinity towards ß-III-neurotubulin with 99mTc. The indirect labelling was ensured through the bifunctional chelator HYNIC, the direct labelling by electrolytic means, and the direct labelling of antibody TU-20 reduced by 2-mercaptoethanol. To observe each single feature, the appropriate chemical and biochemical control methods were used. Chemical purity was ensured by gel filtration and, together with chemical stability, it was checked by paper chromatography. To control the biological stability, SDS electrophoresis was used. The immunoreactivity was checked using ELISA-tests.
RESULTS: The results have shown that the optimal method for labelling the antibody TU-20 is indirect labelling through the bifunctional chelator HYNIC, and the least effective method of labelling the antibody TU-20 is reduced by 2-mercaptoethanol.
DISCUSSION: The results of labelling the monoclonal antibody towards antigen TU-20 with 99mTc confirmed that structure of the monoclonal antibody is destroyed by 2-mercaptoethanol, and in the case of electrolytic labelling, there are not enough binding places for radionuclide 99mTc on the monoclonal antibody.
Get Citation

Keywords

monoclonal antibody; TU-20; 99mTc; HYNIC; 2-mercaptoethanol; radiolabelling.

About this article
Title

Labelling of the anti-III-neurotubulin monoclonal antibody by 99mTc and its binding to responsible antigen

Journal

Nuclear Medicine Review

Issue

Vol 10, No 1 (2007)

Pages

1-5

Published online

2007-02-15

Bibliographic record

Nucl. Med. Rev 2007;10(1):1-5.

Keywords

monoclonal antibody
TU-20
99mTc
HYNIC
2-mercaptoethanol
radiolabelling.

Authors

Katerina Slapnicková
Petra Kolárová
Klára Kynclová

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl